Laura Catena
Milan, 20154, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy.
Journal: Advances in therapy
Published: April 26, 2023
Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement.
Journal: Oncology
Published: July 24, 2018
The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor.
Journal: Journal of geriatric oncology
Published: June 22, 2018
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.
Journal: Endocrine-related cancer
Published: March 15, 2018
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: October 24, 2017
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Journal: Gastroenterology
Published: March 06, 2017
Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update.
Journal: Neuroendocrinology
Published: January 31, 2017
Activity of a three-drug combination including cisplatin (CLOVER regimen) for poorly differentiated neuroendocrine carcinoma.
Journal: Anticancer research
Published: October 03, 2014
Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study.
Journal: Cancer
Published: January 21, 2014
New perspectives in the treatment of neuroendocrine tumours.
Journal: Anticancer research
Published: October 13, 2012
Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?
Journal: Tumori
Published: December 14, 2011
Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges.
Journal: Targeted oncology
Published: November 19, 2010
Showing 1-12 of 12
Last Updated: 09/26/2026